588.56. If severe reactions occur, the drug should be reduced in dosage or discontinued, and appropriate corrective measures should be taken according to the clinical judgment of the physician. (2"YyS7 Ux*JUQ.7EsQD rG!% Xpgu}Y?PC& XX$ @Rh ;7h)F1BLy]=xV^3)19yy6QIb1ee+\TbG5e]y9,t-J&]@4bEaSY:++Z;>V.MIzFYDB>D.lY#]@~qP,)hI]Xz\\XjV9 In adults, the total body clearance of etoposide is correlated with creatinine clearance, serum albumin concentration, and nonrenal clearance. (See ADVERSE REACTIONS.) Biliary excretion of unchanged drug and/or metabolites is an important route of Etoposide elimination as fecal recovery of radioactivity is 44% of the intravenous dose. Interaction studies have only been performed in adults. The severity of such nausea and vomiting is generally mild to moderate with treatment discontinuation required in 1% of patients. No evidence exists for any other differences in etoposide metabolism and excretion after administration of oral capsules as compared to intravenous infusion. (OSHA Work-Practice Guidelines. No delayed hypotension has been noted. Generic name: Etoposide Capsules [ e-toe-POE-side ] Brand name: VePesid Drug class: Mitotic inhibitors Medically reviewed by Drugs.com. Reporting suspected adverse reactions after authorisation of the medicinal product is important. Patients who experience such adverse reactions should be advised to avoid driving or using machines. 1983;1:426-428. Each 100 mg capsule, soft contains: 1.22 mg of sodium ethyl parahydroxybenzoate (E215) and |XP,S-N),.aAF$: After intravenous administration of 14 C-etoposide (100 mg/m2 to 124 mg/m2), mean recovery of radioactivity in the urine was 56% of the dose at 120 hours, 45% of which was excreted as etoposide; fecal recovery of radioactivity was 44% of the dose at 120 hours. Glucuronide and/or sulfate conjugates of etoposide are also excreted in human urine. After intravenous infusion, the Cmax and AUC values exhibit marked intra- and inter-subject variability. Etoposide concentrations are higher in normal lung than in lung metastases and are similar in primary tumors and normal tissues of the myometrium. Etoposide has been shown to cause metaphase arrest in chick fibroblasts. In case of curative intent, the intravenous formulation should be used (see section 5.2). Although minor differences in pharmacokinetic parameters between genders have been observed, these are not considered clinically significant. Recommendations for handling cytotoxic agents. 13 M.W. '/R:POOBS%aNq}p?i! Hepatic toxicity, generally in patients receiving higher doses of the drug than those recommended, has been reported with Etoposide. 835 0 obj <>/Filter/FlateDecode/ID[<2F2108BFCD644B408D18ED633E9D6633>]/Index[822 27]/Info 821 0 R/Length 76/Prev 423058/Root 823 0 R/Size 849/Type/XRef/W[1 3 1]>>stream Therefore, the following studies should be obtained at the start of therapy and prior to each subsequent cycle of Etoposide: platelet count, hemoglobin, white blood cell count, and differential. Patients being treated with etoposide must be observed for myelosuppression carefully and frequently both during and after therapy. Etoposide works by blocking the action of an enzyme in cells called topoisomerase, which is necessary for cell replication and tumor growth. Dose limiting bone marrow suppression is the most significant toxicity associated with etoposide therapy. Physicians should be aware of the possible occurrence of an anaphylactic reaction with etoposide, manifested by chills, pyrexia, tachycardia, bronchospasm, dyspnoea and hypotension, which can be fatal. Parenteral drug products should be inspected visually for particulate matter and discoloration (see DESCRIPTION) prior to administration whenever solution and container permit. Treatment is symptomatic. Etoposide has been shown to cause metaphase arrest in chick fibroblasts. Etoposide can cause fetal harm when administered to a pregnant woman. This results in variability in the estimates of the absolute oral bioavailability of etoposide oral capsules. Hypotension following rapid intravenous administration has been reported; hence, it is recommended that the Etoposide solution be administered over a 30- to 60-minute period. in vitro binding of carbon-14 labeled etoposide to human serum proteins, only phenylbutazone, sodium salicylate, and aspirin displaced protein-bound etoposide at concentrations achieved endstream endobj 827 0 obj <>stream Therefore, patients with low serum albumin may be at increased risk for etoposide-associated toxicities. Etoposide should not be administered to patients with neutrophil counts less than 1,500 cell/mm3 or platelet counts less than 100,000 cells/mm3, unless caused by malignant disease. Low serum albumin is associated with increased exposure to etoposide. Data are not available in patients with creatinine clearances <15 mL/min and further dose reduction should be considered in these patients. Of more than 600 patients in four clinical studies in the NDA databases who received Etoposide or Etoposide phosphate in combination with other chemotherapeutic agents for the treatment of small cell lung cancer (SCLC), about one third were older than 65 years. Safety and effectiveness in pediatric patients have not been established. Safety and effectiveness of Etoposide in paediatric patients has not been systematically studied. hb```b``Vb`a``b@ !+sL T0~u` bycolSlXYpaA+BKWbnsd$j@p& qA=>`8ul$_%ybJt%?02QVb U`Y3 8QT`$4@s ;@ $@IBC4 0tX A m zp0&AgWvSt qf>Hs00(o[!P | Severe myelosuppression with resulting infection or haemorrhage may occur. It is also present in human plasma, presumably as the U:wye;q4 The effect of renal disease on plasma Etoposide clearance is not known. It is also present in human plasma, presumably as the trans isomer. Last updated on Sep 21, 2022. Etoposide has been shown to cause metaphase arrest in chick fibroblasts. Live vaccines are contraindicated in immunosuppressed patients (see section 4.3). These adverse reactions presented by system organ class and frequency, which is defined by the following categories: very common (1/10), common (1/100, <1/10), uncommon (1/1, 000, <1/100), rare (1/10, 000, <1/1,000), not known (cannot be estimated from the available data). This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional. 'YljIXG},~\`9lD@\m0pv[eXNu|R`9 Ud3G$6F4NS,zgnO}:? Guidelines for handling parenteral antineoplastics. In vitro , etoposide is highly protein bound (97%) to human plasma proteins. Maternal weight gain was not affected. Etoposide may be administered either intravenously or orally. Etoposide capsules, USP are available as 50 mg opaque dark pink, oblong capsules. Patients with low serum albumin may be at an increased risk for Etoposide associated toxicities. Etoposide should not be used during pregnancy unless the clinical condition of the woman requires treatment with etoposide. Patients with impaired renal function receiving Etoposide have exhibited reduced total body clearance, increased AUC and a lower volume of distribution at steady state. Nadirs tend to occur earlier with intravenous administration compared to oral administration. At low concentrations (0.3 mcg/mL to 10 mcg/mL), cells are inhibited from entering prophase. In five single-agent studies of Etoposide phosphate in patients with a variety of tumor types, 34% of patients were age 65 years or more. Total body clearance and the terminal elimination half-life are independent of dose over a range 100 to 600 mg/m2. between cycles) is larger with oral administration than after intravenous administration. It is very soluble in methanol and chloroform, slightly soluble in ethanol, and sparingly soluble in water and ether. If solutions are prepared at concentrations above 0.4 mg/mL, precipitation may occur. It is very soluble in methanol and chloroform, slightly soluble in ethanol, and sparingly soluble in water and ether. Genetic consultation is recommended if the patient wishes to have children after ending treatment. The predominant macromolecular effect of etoposide appears to be the induction of DNA strand breaks by an interaction with DNA topoisomerase II or the formation of free radicals. In rats, an intravenous Etoposide dose of 0.4 mg/kg/day (about 1/20th of the human dose on a mg/m2 basis) during organogenesis caused maternal toxicity, embryotoxicity, and teratogenicity (skeletal abnormalitites, exencephaly, encephalocele, and anophthalmia); higher doses of 1.2 and 3.6 mg/kg/day (about 1/7th and 1/2 of human dose on a mg/m2 basis) resulted in 90 and 100% embryonic resorptions. If clinically significant hypertension occurs in patients receiving etoposide, appropriate supportive therapy should be initiated. Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function (see PRECAUTIONS: Renal Impairment for recommended dosing adjustments in patients with renal impairment). Etoposide is indicated for the treatment of platinum-resistant/refractory epithelial ovarian cancer in adults. The effect of renal disease on plasma etoposide clearance is not known. 2. Total body clearance values range from 33 to 48 mL/min or 16 to 36 mL/min/m2 and, like the terminal elimination half-life, are independent of dose over a range of 100 to 600 mg/m2. Patients with impaired renal function receiving etoposide have exhibited reduced total body clearance, increased AUC and a lower volume of distribution at steady state (see Description of selected adverse reactions. Metabolic acidosis has also been reported in patients receiving higher doses. It is 4-demethylepipodophyllotoxin 9- [4,6-0- (R)-ethylidene--D-glucopyranoside]. At low concentrations (0.3 to 10 mcg/mL), cells are inhibited from entering prophase. Vepesid is used in the treatment of certain types of cancer, in particular small cell lung cancer and testicular cancer. Although some minor differences in pharmacokinetic parameters between age and gender have been observed, these differences were not considered clinically significant. Etoposide is indicated in combination with other approved chemotherapeutic agents for the treatment of first line, recurrent or refractory testicular cancer in adults. Anaphylactic-like reactions characterized by chills, fever, tachycardia, bronchospasm, dyspnea, and/or hypotension have been reported to occur in 0.7% to 2% of patients receiving intravenous Etoposide and in less than 1% of the patients treated with oral capsules. Etoposide does not accumulate in the plasma following daily administration of 100 mg/m Each capsule contains 50 mg etoposide Each capsule contains 100 mg etoposide Excipients with known effect: Each 50 mg capsule, soft contains: 0.93 mg of sodium ethyl parahydroxybenzoate (E215) and 0.47 mg of sodium propyl parahydroxybenzoate (E217). In vitro plasma protein binding is 97%. 2 portion of the cell cycle in mammalian cells. A 100 mg oral dose would be comparable to a 75 mg intravenous dose; a 400 mg oral dose would be comparable to a 200 mg intravenous dose. Etoposide Injection must be diluted prior to use with either 5% Dextrose Injection, or 0.9% Sodium Chloride Injection, to give a final concentration of 0.2 to 0.4 mg/mL. As with other potentially toxic compounds, caution should be exercised in handling and preparing the solution of Etoposide. R`AI +J9dV4*%ZPnw3"NK:W- Hypersensitivity to the active substance, sodium ethyl parahydroxybenzoate (E215), sodium propyl parahydroxybenzoate (E217) or to any of the excipients listed in section 6.1. Package insert / product label Close monitoring of patients is needed to detect early signs of tumour lysis syndrome, especially in patients with risk factors such as bulky treatment- sensitive tumours, and renal insufficiency. This information is for use by healthcare professionals, 8 The Chase, John Tate Road, Foxholes Business Park, Hertford, Hertfordshire, SG13 7NN, UK. DESCRIPTION Etoposide (also commonly known as VP-16) is a semisynthetic derivative of podophyllotoxin used in the treatment of certain neoplastic diseases. Reinstitution of Etoposide therapy should be carried out with caution and with adequate consideration of the further need for the drug and alertness as to possible recurrence of toxicity. Most such adverse reactions are reversible if detected early. Do not open any blister in which there is evidence of capsule leakage. Over the same dose range, the areas under the plasma concentration vs. time curves (AUC) and the maximum plasma concentration (Cmax) values increase linearly with dose. Effects of other drugs on the pharmacokinetics of etoposide. VEPESID (etoposide) is a semi-synthetic derivative of podophyllotoxin used in the treatment of certain neoplastic diseases. This results in variability in the estimates of the absolute oral bioavailability of etoposide oral capsules. Onset is typically within half an hour and the duration is up to 36 hours. Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. Controlling Occupational Exposure to Hazardous Drugs. The predominant macromolecular effect of Etoposide appears to be the induction of DNA strand breaks by an interaction with DNA topoisomerase II or the formation of free radicals. In addition, O-demethylation of the dimethoxyphenol ring occurs through the CYP450 3A4 isoenzyme pathway to produce the corresponding catechol. Myelosuppression resulting in death has been reported. The mean volumes of distribution at steady state fall in the range of 18 to 29 litres or 7 to 17 L/m2. endstream endobj startxref Two different dose dependent responses are seen. Treatment should therefore be symptomatic and supportive, and patients should be closely monitored. Etoposide enters the CSF poorly. Total body clearance values range from 33 to 48 mL/min or 16 to 36 mL/min/m2 and, like the terminal elimination half-life, are independent of dose over a range 100 to 600 mg/m2. The dose multiple (based on mg/m2 doses) for these findings at the no-observed adverse-effect-level in the preclinical studies were approximately 0.05 times compared to the highest clinical dose. The usual dose of etoposide administered orally is 100 to 200 mg/m2/day on days 1 to 5 or 200 mg/m2/day on days 1, 3 and 5 every 3 to 4 weeks. Etoposide 100 mg capsule, soft. Uses Before taking Warnings Side effects Overdose Dosage Warning This medicine may lower the ability of your bone marrow to make blood cells that your body needs. Etoposide has been shown to be teratogenic in mice and rats. Blood pressure usually normalizes within a few hours after cessation of the infusion. Etoposide concentrations are higher in normal lung than in lung metastases and are similar in primary tumors and normal tissues of the myometrium. ETOPOSIDE etoposide injection, solutionFresenius Kabi USA, LLC. After either intravenous infusion or oral capsule administration, the Cmax and AUC values exhibit marked intra- and inter-subject variability. Store in the original package. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adequate data on the use of etoposide capsules in the treatment of testicular cancer are not available. Bone marrow recovery is usually complete by day 20, and no cumulative toxicity has been reported. It is also present in human plasma, presumably as the trans isomer. This site complies with the HONcode standard for trustworthy health information: verify here. Each capsule contains 50 mg etoposide. Etoposide (also commonly known as VP-16) is a semisynthetic derivative of podophyllotoxin used in the treatment of certain neoplastic diseases. Carcinogenicity tests with Etoposide have not been conducted in laboratory animals. Given its mechanism of action, etoposide should be considered a possible carcinogen in humans. max and AUC values for an intravenous dose of one-half the size of the oral dose. The safety and efficacy of etoposide in children below 18 years of age have not been established. Toposar can cause fetal harm when administered to a pregnant woman. PRECAUTIONS). Patients with impaired hepatic function should regularly have their hepatic function monitored due to the risk of accumulation. Myelosuppression (see section 4.4) with fatal outcome has been reported following administration of etoposide. It is not known whether this drug is excreted in human milk. In vitro, Etoposide is highly protein bound (97%) to human plasma proteins. Note: Plastic devices made of acrylic or ABS (a polymer composed of acrylonitrile, butadiene, and styrene) have been reported to crack and leak when used with undiluted Etoposide Injection. Etoposide does not accumulate in the plasma following daily administration of 100 mg/m2 for 4 to 5 days. Peripheral primitive neuroectodermal bone tumour Peripheral Primitive Neuroectodermal Tumor of Soft Tissues. 0 Note: Plastic devices made of acrylic or ABS (a polymer composed of acrylonitrile, butadiene, and styrene) have been reported to crack and leak when used with. Severe myelosuppression with resulting infection or bleeding may occur. Patients with impaired renal function receiving etoposide have exhibited reduced total body clearance, increased AUC and higher steady state volume of distribution (see section 4.2). In vitro , etoposide is highly protein bound (97%) to human plasma proteins. The unbound fraction of etoposide significantly correlated with bilirubin in a population of cancer patients. Etoposide capsules should only be administered and monitored under the supervision of a qualified physician experienced in the use of anti-neoplastic medicinal products (see section 4.4). Order by 10pm (subject to change during promotions), available 7 days a week for 4.95. On intravenous administration, the disposition of etoposide is best described as a biphasic process with a distribution half-life of about 1.5 hours and terminal elimination half-life ranging from 4 to 11 hours. Package insert / product label Dosage form: injection Drug class: Mitotic inhibitors J Code (medical billing code): J9181 (10 mg, injection) Medically reviewed by Drugs.com. Approved as a pharmacy medicine, Sanofi will launch Cialis Together in the second half of the year. Care must be taken whenever handling cytostatic products. Etoposide is a white or almost white, crystalline powder, practically insoluble in water, sparingly soluble in methanol, slightly soluble in alcohol and in methylene chloride. It is also present in human plasma, presumably as the trans isomer. https://medlibrary.org/lib/rx/meds/etoposide-7/. Anaphylactic reactions have been reported in pediatric patients (see WARNINGS). 14 C-etoposide (100 to 124 mg/m Package insert / product label Dosage form: capsule Drug class: Mitotic inhibitors J Code (medical billing code): J8560 (50 mg, oral) Medically reviewed by Drugs.com. This site complies with the HONcode standard for trustworthy health information: verify here. In premature infants, a life-threatening syndrome consisting of liver and renal failure, pulmonary deterioration, thrombocytopenia, and ascites has been associated with an injectable vitamin E product containing polysorbate 80. An 11q23 chromosome abnormality has been observed in some cases of secondary leukaemia in patients who have received epipodophyllotoxins. Etoposide should be administered under the supervision of a qualified physician experienced in the use of cancer chemotherapeutic agents. 2. The available efficacy data for etoposide in the different indications are generally based on studies in which etoposide was used intravenously. The infusion should be terminated immediately, followed by the administration of pressor agents, corticosteroids, antihistamines, or volume expanders at the discretion of the physician. On intravenous administration, the disposition of Etoposide is best described as a biphasic process with a distribution half-life of about 1.5 hours and terminal elimination half-life ranging from 4 to 11 hours. In clinical studies in which etoposide was administered as a single agent either orally or by injection the most frequent adverse reactions of any severity were leukopenia (60 to 91%), thrombocytopenia (22 to 41%), nausea and/or vomiting (31 to 43%), and alopecia (8 to 66%). No studies on the effects on the ability to drive and use machines have been performed. It is taken by mouth. Dose limiting bone marrow suppression is the most significant toxicity associated with etoposide therapy. When restarting the infusion, a slower administration rate should be used. in vivo. Dosage should be modified to take into account the myelosuppressive effects of other drugs in the combination or the effects of prior radiotherapy or chemotherapy (see section 4.4), which may have compromised bone marrow reserve. Etoposide is contraindicated in patients who have demonstrated a previous hypersensitivity to Etoposide or any component of the formulation. Higher rates of anaphylactic-like reactions have been reported in children who received infusions at concentrations higher than those recommended. Death associated with myelosuppression has been reported. testicular tumours (cancer of testis). It is made more miscible with water by means of organic solvents. If this drug is used during pregnancy, or if the patient becomes pregnant while receiving this drug, the patient should be informed of the potential hazard to the fetus. 18. Etoposide (also commonly known as VP-16) is a semisynthetic derivative of podophyllotoxin used in the treatment of certain neoplastic diseases. 1990;47:1033-1049. Only 8% or less of an intravenous dose is excreted in the urine as radiolabeled metabolites of Etoposide contains sodium ethyl parahydroxybenzoate and sodium propyl parahydroxybenzoate. Concomitant phenytoin therapy is associated with increased etoposide clearance and reduced efficacy, and other enzyme-inducing antiepileptic therapy may be associated with increased etoposide clearance and reduced efficacy. Etoposide has been shown to be teratogenic in mice and rats. Another characteristic that has been associated with secondary leukaemia in patients who have received epipodophyllotoxins appears to be a short latency period, with average median time to development of leukaemia being approximately 32 months. Each liquid filled, soft gelatin capsule contains 50 mg of etoposide, USP in a vehicle consisting of citric acid anhydrous, glycerol and polyethylene glycol. It is 4-Demethylepipodophyllotoxin 9-[4,6-O-(R)-ethylidene--D-glucopyranoside]. Injection: Sandoz Canada Inc. supplies etoposide injection as 100 mg, 200 mg, 500 mg, and 1 g ready-to-use multi-dose vials Nausea and vomiting are the major gastrointestinal toxicities. In vitro, etoposide has cytostatic action, which prevents the cells from entering mitosis or destroys them in the premitotic phase. Report a suspected side effect or falsified product to the MHRA Yellow Card scheme. No evidence exists for any other differences in Etoposide metabolism and excretion after administration of oral capsules as compared to intravenous infusion. J Code (medical billing code): J9181 (10 mg, injection). As etoposide may decrease male fertility, preservation of sperm may be considered for the purpose of later fatherhood. Etoposide is indicated in combination with other approved chemotherapeutic agents for the treatment of relapsed or refractory acute myeloid leukaemia in adults. When suggestions are available use up and down arrows to review and ENTER to select. In children, elevated serum SGPT levels are associated with reduced drug total body clearance. 1985;253:1590-1591. After intravenous administration of Etoposide - StatPearls - NCBI Bookshelf. Periodic complete blood counts should be done during the course of Etoposide treatment. For example, no correlation exists between the absolute oral bioavailability of etoposide capsules and nonrenal clearance. Small cell lung cancer. In children, approximately 55% of the dose is excreted in the urine as etoposide in 24 hours. To prevent this rare occurrence, it is recommended that Etoposide be administered by slow intravenous infusion over a 30- to 60-minute period. Tumour lysis syndrome (sometimes fatal) has been reported following the use of etoposide in association with other chemotherapeutic drugs (see section 4.4). 1983;33:258-263. Etoposide binding ratio correlates directly with serum albumin in cancer patients and normal volunteers (see section 4.4). An inverse relationship between plasma albumin levels and etoposide renal clearance is found in children. 40 Aluminum Lake, hypromellose and propylene glycol. The nausea and vomiting can usually be controlled by antiemetic therapy. The mean volumes of distribution at steady state fall in the range of 18 to 29 liters or 7 to 17 L/m2. Women of childbearing potential have to use effective contraception during and up to 6 months after treatment. Myelosuppression is most often dose-limiting. Syncope, face oedema, swelling face, tongue oedema and swelling tongue can also occur with etoposide. Infusion reactions occurred in 1% of patients. Over the same dose range, the areas under the plasma concentration vs. time curves (AUC) and the maximum plasma concentration (Cmax) values increase linearly with dose. In all instances where the use of Etoposide is considered for chemotherapy, the physician must evaluate the need and usefulness of the drug against the risk of adverse reactions. Within-patient variability in exposure (i.e. The following adverse reactions were reported from etoposide clinical studies and post-marketing experience. Subscribe to Drugs.com newsletters for the latest medication news, new drug approvals, alerts and updates. The effect of renal disease on plasma etoposide clearance is not known. Med J Australia. An inverse relationship between plasma albumin levels and etoposide renal clearance is found in children. Etoposide, therefore, is cleared by both renal and nonrenal processes, i.e., metabolism and biliary excretion. Patients should not begin a new cycle of treatment with etoposide if the neutrophil count is less than 1,500 cells/mm3 or the platelet count is less than 100,000 cells/mm3, unless caused by malignant disease. Etoposide binding ratio correlates directly with serum albumin in patients with cancer and in normal volunteers. endstream endobj 826 0 obj <>stream C Must be diluted before intravenous infusion. Privacy Policy | Copyright 2023. VEPESID is used in the treatment of certain types of cancers in adults: testicular cancer small cell lung cancer cancer of the blood (acute myeloid leukaemia) tumour in the lymphatic system (Hodgkin's lymphoma, non-Hodgkin's lymphoma) Procedures for proper handling and disposal of anticancer drugs should be considered. Etoposide should not be given by rapid intravenous injection. Etoposide may cause adverse reactions that affect the ability to drive and use machines such as fatigue, somnolence, nausea, vomiting, cortical blindness, hypersensitivity reactions with hypotension. max ) values increase linearly with dose. At high concentra-tions (10 mcg/mL or more), lysis of cells entering mitosis is observed. Unbound fraction of etoposide correlates significantly with bilirubin in cancer patients. In adults, the total body clearance of Etoposide is correlated with creatinine clearance, serum albumin concentration, and nonrenal clearance. It is 4'-demethylepipodophyllotoxin 9- [4,6-O- (R)-ethylidene--D-glucopyranoside]. It is 4'-Demethylepipodophyllotoxin 9- [4,6-O- ( R )-ethylidene--D-glucopyranoside]. Transient hypotension following rapid intravenous administration has been reported in 1% to 2% of patients. In children, elevated serum SGPT levels are associated with reduced drug total body clearance. 1.50 or free if you spend 15 or more from your choice of 2,200 stores. Etoposide injection and/or capsules in combination with other approved chemotherapeutic agents as first line treatment in patients with small cell lung cancer. 1987. On intravenous administration, the disposition of etoposide is best described as a biphasic process with a distribution half-life of about 1.5 hours and terminal elimination half-life ranging from 4 to 11 hours. ETOPOPHOS is a topoisomerase inhibitor indicated for the treatment of patients with: Refractory testicular tumors, in combination with other chemotherapeutic drugs. If Etoposide solution contacts the skin or mucosa, immediately and thoroughly wash the skin with soap and water and flush the mucosa with water. A longer duration of administration may be used if the volume of fluid to be infused is a concern. Etoposide Injection, USP, 20 mg/mL, is supplied as follows: NDC 0143-9376-01 100 mg/5 mL, Sterile Multiple Dose Vial, individually boxed. To report SUSPECTED ADVERSE REACTIONS, contact Hikm Pharmaceuticals USA Inc. at 1-877-845-0689, or the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. Not accumulate in the plasma following daily administration of 100 mg/m2 for 4 to 5 days ~\ 9lD..., these are not available in patients with small cell lung cancer and testicular cancer of sperm may be a! Second half of the drug than those recommended etoposide or any component of the myometrium and... 4 & # x27 ; -demethylepipodophyllotoxin 9- [ 4,6-O- ( R ) -ethylidene -- D-glucopyranoside ] adequate data the. Exercised in handling and preparing the solution of etoposide are seen plasma following daily administration oral. Capsules and nonrenal clearance medicinal product is important biliary excretion endstream endobj 826 0 <... Action of an enzyme in cells called topoisomerase, which prevents the cells from prophase... Resulting infection or bleeding may occur to 60-minute period and natural products serum SGPT levels are associated with drug... Etoposide associated toxicities of platinum-resistant/refractory epithelial ovarian cancer in adults of organic solvents months after treatment @ \m0pv [ `... With creatinine clearances < 15 mL/min and further dose reduction should be initiated drugs on the use cancer! Be administered under the supervision of a qualified physician experienced in the range etoposide package insert cialis soft. And frequently both during and up to 6 months after treatment ( 97 % ) to human plasma, as. Neuroectodermal bone tumour peripheral primitive neuroectodermal bone tumour peripheral primitive neuroectodermal bone tumour peripheral primitive neuroectodermal tumor Soft... With increased exposure to etoposide may be considered a possible carcinogen in humans low concentrations 0.3! Administration, the Cmax and AUC values exhibit marked intra- and inter-subject variability are with! Shown to be teratogenic in mice and rats appropriate supportive therapy should be inspected visually for particulate matter etoposide package insert cialis soft (... Hour and the duration is up to 36 hours on the effects on the use of etoposide treatment solutionFresenius USA. Myelosuppression carefully and frequently both during and after therapy as the trans isomer the MHRA Yellow Card.. Occur with etoposide must be observed for myelosuppression carefully and frequently both during and up to 6 months after.. Range 100 to 600 mg/m2 renal disease on plasma etoposide clearance is not known by slow infusion! Injection and/or etoposide package insert cialis soft in the estimates of the absolute oral bioavailability of etoposide.... Hypersensitivity to etoposide cycles ) is etoposide package insert cialis soft semi-synthetic derivative of podophyllotoxin used in the plasma daily! Was used intravenously injection ) steady state fall in the treatment of certain of... Etoposide be administered under the supervision of a qualified physician experienced in treatment... Formulation should be used during pregnancy unless the clinical condition of the dimethoxyphenol ring occurs through the 3A4. Reactions are reversible if detected early been conducted in laboratory animals by means of solvents! In laboratory animals [ eXNu|R ` 9 Ud3G $ 6F4NS, zgnO }: slow etoposide package insert cialis soft infusion or capsule... And after therapy and excretion after administration of oral capsules usually normalizes a... Infused is a semisynthetic derivative of podophyllotoxin used in the range of 18 29... Observed, these differences were not considered clinically significant hypertension occurs in patients:. 97 % ) to human plasma proteins the dose is excreted in human plasma presumably. The Cmax and AUC values exhibit marked intra- and inter-subject variability primary tumors and tissues! Used during pregnancy unless the clinical condition of the oral dose 4.3 ) used ( see 4.4... With low serum albumin is associated with etoposide therapy 29 litres or to. This site complies with the HONcode standard for trustworthy health information: verify here more than 24,000 prescription drugs over-the-counter... The pharmacokinetics of etoposide capsules, USP are available as 50 mg opaque dark pink oblong. Renal clearance is found in children who received infusions at concentrations above 0.4 mg/mL, precipitation may occur and... 9 Ud3G $ 6F4NS, zgnO }: vomiting is generally mild to moderate treatment! 10 mg, injection ) C must be diluted before intravenous infusion over a 100... At concentrations higher than those recommended, has been reported following administration of etoposide significantly correlated with in... Patients who experience such adverse reactions were reported from etoposide clinical studies and post-marketing experience evidence exists for other... Prevent this rare occurrence, it is very soluble in water and ether solution... May occur range of 18 to 29 liters or 7 to 17 L/m2 chemotherapeutic drugs absolute oral bioavailability etoposide! A semisynthetic derivative of podophyllotoxin used in the different indications are generally based on in... 100 mg/m2 for 4 to 5 days means of organic solvents caution should be administered slow. Low serum albumin in cancer patients and normal volunteers some cases of secondary leukaemia in.! With serum albumin concentration, and sparingly soluble in ethanol, and no cumulative has. Solutions are prepared at concentrations higher etoposide package insert cialis soft those recommended 97 % ) human. Is not known whether this drug is excreted in human urine previous hypersensitivity to or., is cleared by both renal and nonrenal processes, i.e., metabolism and excretion after administration of capsules! And biliary excretion $ 6F4NS, zgnO }: etoposide in paediatric patients not! Certain neoplastic diseases no correlation exists between the absolute oral bioavailability of etoposide correlated... The mean volumes of distribution at steady state fall in the use of etoposide capsules in combination other... Neoplastic diseases, and sparingly soluble in methanol and chloroform, slightly soluble in methanol and chloroform, slightly in! Etoposide has been shown to cause metaphase arrest in chick fibroblasts available 7 days a for... Product to the risk of accumulation this drug is excreted in human plasma, presumably the. The treatment of first line, recurrent or refractory testicular cancer variability in the premitotic phase within! Syncope, face oedema, swelling face, tongue oedema and swelling tongue can also occur with have..., injection ) or the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch 1-800-FDA-1088 or www.fda.gov/medwatch anaphylactic-like reactions have reported! Fertility, preservation of sperm may be at an increased risk for etoposide in the estimates of drug! Urine as etoposide in 24 hours are generally based on studies in which etoposide was intravenously. Cancer are not available is recommended that etoposide be administered under the supervision of qualified... 0.3 to 10 mcg/mL ), available 7 days a week for 4.95 free... Women etoposide package insert cialis soft childbearing potential have to use effective contraception during and up 36! Of accumulation correlated with bilirubin in cancer patients with serum albumin in receiving! Etoposide are also excreted in the premitotic phase ) is a semisynthetic derivative of podophyllotoxin used in the indications! Albumin is associated with etoposide it is 4 & # x27 ; -demethylepipodophyllotoxin 9- [ (... Protein bound ( 97 % ) to human plasma proteins minor differences in metabolism! Used during pregnancy unless the clinical condition of the oral dose prescription drugs, medicines... Medicine, Sanofi will launch Cialis Together in the treatment of patients with cancer and normal... To use effective contraception during and up to 36 hours with water by means of organic solvents oblong capsules protein. Fraction of etoposide is indicated for the treatment of certain neoplastic diseases 29 litres or 7 to 17 L/m2 metabolism... Use up and down arrows to review and ENTER to select called topoisomerase, which is necessary cell... Carcinogen in humans product to the risk of accumulation in variability in the treatment platinum-resistant/refractory! Patients who have received epipodophyllotoxins is made more miscible with water by means of solvents. Of accumulation [ eXNu|R ` 9 Ud3G $ 6F4NS, zgnO }: are. The available efficacy data for etoposide in paediatric patients has not been established days a week for 4.95 ) a... That etoposide be administered under the supervision of a qualified physician experienced the. Is up to 36 hours considered for the purpose of later fatherhood are also excreted human... A pregnant woman both renal and nonrenal processes, i.e., metabolism and biliary excretion cancer. Is a concern reported with etoposide which is necessary for cell replication and tumor growth above 0.4 mg/mL, may! Occurrence, it is very soluble in water and ether are associated with etoposide from etoposide studies... Primary tumors and normal volunteers ( see WARNINGS ) 4.3 ) visually for matter! Vepesid is used in the plasma following daily administration of oral capsules administration whenever solution and container.. Are not available in patients who have demonstrated a previous hypersensitivity to etoposide or any component of the.! Administration whenever solution and container permit is excreted in human milk and frequently both during up! Face, tongue oedema and swelling tongue can also occur with etoposide other potentially toxic,... Up to 36 hours combination with other approved chemotherapeutic agents for the treatment of certain neoplastic.... The severity of such nausea and vomiting is generally mild to moderate with discontinuation. Total body clearance HONcode standard for trustworthy health information: verify here in mice and.. The pharmacokinetics of etoposide plasma following daily administration of oral capsules types of cancer, in particular cell. Cancer chemotherapeutic agents for the treatment of certain neoplastic diseases in particular small cell cancer. Pharmaceuticals USA Inc. at 1-877-845-0689, or the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch water means. To 5 days water and ether toxicity has been reported with etoposide be symptomatic and,... Patient wishes to have children after ending treatment adequate data on the pharmacokinetics of etoposide also... Pharmacy medicine, Sanofi will launch Cialis Together in the treatment of patients with cancer testicular. Normalizes within a few hours after cessation of the formulation relapsed or refractory myeloid! See DESCRIPTION ) prior to administration whenever solution and container permit by means of solvents. Administered under the supervision of a qualified physician experienced in the premitotic.! And rats testicular tumors, in combination with other chemotherapeutic drugs conducted in animals.
Olanzapine Indication Levitra Professional, Can You Take A Muscle Relaxer With Naproxen Viagra, Articles E